FDA head says he is willing to fast-track COVID-19 vaccine

Financial Times

30 August 2020 - Stephen Hahn insists he will not rush process just to help Donald Trump’s election chances.

The head of the US Food and Drug Administration has said he is willing to bypass the normal approval process to authorise a COVID-19 vaccine as soon as possible — but has insisted he will not do so to please President Donald Trump.

In an interview with the Financial Times, Stephen Hahn said his agency was prepared to authorise a vaccine before Phase 3 clinical trials were complete, as long as officials believed the benefits outweighed the risks. But he defended his embattled organisation against accusations that it was rushing the process to boost Mr Trump’s re-election prospects.

Read Financial Times article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Outcome , US , Timelines , Vaccine , COVID-19